AAAAAA
Results: 101-125/158
Authors:
PEREIRA J
BRUERA E
Citation: J. Pereira et E. Bruera, SUCCESSFUL MANAGEMENT OF INTRACTABLE NAUSEA WITH ONDANSETRON - A CASE-STUDY, Journal of palliative care, 12(2), 1996, pp. 47-50
Authors:
MCINTYRE E
BRUERA E
Citation: E. Mcintyre et E. Bruera, SYMPTOMATIC HYPOCALCEMIA AFTER INTRAVENOUS PAMIDRONATE, Journal of palliative care, 12(1), 1996, pp. 46-47
Authors:
FAINSINGER RL
BRUERA E
Citation: Rl. Fainsinger et E. Bruera, HOW SHOULD WE USE TRANSDERMAL FENTANYL (TF) FOR PAIN MANAGEMENT IN PALLIATIVE CARE PATIENTS, Journal of palliative care, 12(1), 1996, pp. 48-53
Authors:
BRUERA E
SLOAN P
MOUNT B
SCOTT J
SUAREZALMAZOR M
Citation: E. Bruera et al., A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, CROSSOVER TRIAL COMPARING THE SAFETY AND EFFICACY OF ORAL SUSTAINED-RELEASE HYDROMORPHONE WITH IMMEDIATE-RELEASE HYDROMORPHONE IN PATIENTS WITH CANCER PAIN, Journal of clinical oncology, 14(5), 1996, pp. 1713-1717
Authors:
BRUERA E
Citation: E. Bruera, PATIENT ASSESSMENT IN PALLIATIVE CANCER CARE, Cancer treatment reviews, 22, 1996, pp. 3-12
Authors:
WATANABE S
BELZILE M
KUEHN N
HANSON J
BRUERA E
Citation: S. Watanabe et al., CAPSULES AND SUPPOSITORIES OF METHADONE FOR PATIENTS ON HIGH-DOSE OPIOIDS FOR CANCER PAIN - CLINICAL AND ECONOMIC-CONSIDERATIONS, Cancer treatment reviews, 22, 1996, pp. 131-136
Authors:
VIGANO A
FAN D
BRUERA E
Citation: A. Vigano et al., INDIVIDUALIZED USE OF METHADONE AND OPIOID ROTATION IN THE COMPREHENSIVE MANAGEMENT OF CANCER PAIN ASSOCIATED WITH POOR PROGNOSTIC INDICATORS, Pain, 67(1), 1996, pp. 115-119
Authors:
FAINSINGER RL
BRUERA E
WATANABE S
Citation: Rl. Fainsinger et al., REHYDRATION IN PALLIATIVE CARE, Palliative medicine, 10(2), 1996, pp. 165-166
Authors:
WALKER P
WATANABE S
LAWLOR P
BRUERA E
Citation: P. Walker et al., SUBCUTANEOUS CLODRONATE, Lancet, 348(9023), 1996, pp. 345-346
Authors:
BRUERA E
PEREIRA J
WATANABE S
BELZILE M
KUEHN N
HANSON J
Citation: E. Bruera et al., OPIOID ROTATION IN PATIENTS WITH CANCER PAIN - A RETROSPECTIVE COMPARISON OF DOSE RATIOS BETWEEN METHADONE, HYDROMORPHONE, AND MORPHINE, Cancer, 78(4), 1996, pp. 852-857
Authors:
BRUERA E
SCHOELLER MT
STJERNSWARD J
Citation: E. Bruera et al., OPIOID AVAILABILITY IN LATIN-AMERICA - THE DECLARATION OF FLORIANOPOLIS, Supportive care in cancer, 3(3), 1995, pp. 164-167
Authors:
BRUERA E
MOYANO J
SEIFERT L
FAINSINGER RL
HANSON J
SUAREZALMAZOR M
Citation: E. Bruera et al., THE FREQUENCY OF ALCOHOLISM AMONG PATIENTS WITH PAIN DUE TO TERMINAL CANCER, Journal of pain and symptom management, 10(8), 1995, pp. 599-603
Authors:
BRUERA E
DESTOUTZ ND
FAINSINGER RL
SPACHYNSKI K
SUAREZALMAZOR M
HANSON J
Citation: E. Bruera et al., COMPARISON OF 2 DIFFERENT CONCENTRATIONS OF HYALURONIDASE IN PATIENTSRECEIVING ONE-HOUR INFUSIONS OF HYPODERMOCLYSIS, Journal of pain and symptom management, 10(7), 1995, pp. 505-509
Authors:
FAINSINGER RL
BRUERA E
Citation: Rl. Fainsinger et E. Bruera, IS THIS OPIOID ANALGESIC TOLERANCE, Journal of pain and symptom management, 10(7), 1995, pp. 573-577
Authors:
SMITH P
BRUERA E
Citation: P. Smith et E. Bruera, MANAGEMENT OF MALIGNANT URETERAL OBSTRUCTION IN THE PALLIATIVE CARE SETTING, Journal of pain and symptom management, 10(6), 1995, pp. 481-486
Authors:
BRUERA E
SCHOELLER T
WENK R
MACEACHERN T
MARCELINO S
HANSON J
SUAREZALMAZOR M
Citation: E. Bruera et al., A PROSPECTIVE MULTICENTER ASSESSMENT OF THE EDMONTON STAGING SYSTEM FOR CANCER PAIN, Journal of pain and symptom management, 10(5), 1995, pp. 348-355
Authors:
DESTOUTZ ND
BRUERA E
SUAREZALMAZOR M
Citation: Nd. Destoutz et al., OPIOID ROTATION FOR TOXICITY REDUCTION IN TERMINAL CANCER-PATIENTS, Journal of pain and symptom management, 10(5), 1995, pp. 378-384
Authors:
HUNT G
BRUERA E
Citation: G. Hunt et E. Bruera, RESPIRATORY DEPRESSION IN A PATIENT RECEIVING ORAL METHADONE FOR CANCER PAIN, Journal of pain and symptom management, 10(5), 1995, pp. 401-404
Authors:
BRUERA E
FRANCO JJ
MALTONI M
WATANABE S
SUAREZALMAZOR M
Citation: E. Bruera et al., CHANGING PATTERN OF AGITATED IMPAIRED MENTAL STATUS IN PATIENTS WITH ADVANCED CANCER - ASSOCIATION WITH COGNITIVE MONITORING, HYDRATION, AND OPIOID ROTATION, Journal of pain and symptom management, 10(4), 1995, pp. 287-291
Authors:
THOMAS Z
BRUERA E
Citation: Z. Thomas et E. Bruera, USE OF METHADONE IN A HIGHLY TOLERANT PATIENT RECEIVING PARENTERAL HYDROMORPHONE, Journal of pain and symptom management, 10(4), 1995, pp. 315-317
Authors:
KOVACS CS
MACDONALD SM
CHIK CL
BRUERA E
Citation: Cs. Kovacs et al., HYPERCALCEMIA OF MALIGNANCY IN THE PALLIATIVE CARE PATIENT - A TREATMENT STRATEGY, Journal of pain and symptom management, 10(3), 1995, pp. 224-232
Authors:
STJERNSWARD J
BRUERA E
JORANSON D
ALLENDE S
MONTEJO G
TRISTAN LQ
CASTILLO G
SCHOELLER T
PAZOS MAR
WENK R
PRUVOST M
DELIMA L
MENDEZ E
OLARTE JN
OLALLA JF
VANEGAS G
Citation: J. Stjernsward et al., OPIOID AVAILABILITY IN LATIN-AMERICA - THE DECLARATION OF FLORIANOPOLIS, Journal of pain and symptom management, 10(3), 1995, pp. 233-236
Authors:
BRUERA E
Citation: E. Bruera, A NATIONAL-CANCER-INSTITUTE OF CANADA WORKSHOP ON SYMPTOM CONTROL ANDSUPPORTIVE CARE IN PATIENTS WITH ADVANCED CANCER - METHODOLOGICAL ANDADMINISTRATIVE ISSUES, Journal of pain and symptom management, 10(2), 1995, pp. 129-130
Authors:
BREITBART W
BRUERA E
CHOCHINOV H
LYNCH M
Citation: W. Breitbart et al., NEUROPSYCHIATRIC SYNDROMES AND PSYCHOLOGICAL SYMPTOMS IN PATIENTS WITH ADVANCED CANCER, Journal of pain and symptom management, 10(2), 1995, pp. 131-141
Authors:
MACDONALD N
ALEXANDER HR
BRUERA E
Citation: N. Macdonald et al., CACHEXIA-ANOREXIA-ASTHENIA, Journal of pain and symptom management, 10(2), 1995, pp. 151-155